The Markers in Neurpsychiatric Disorders (MiND) Study is exploring blood biomarkers to improve early and timely diagnosis for people with cognitive, psychiatric and neurological symptoms. The ultimate goal of this research is to lead to routine, clinically available tests that would improve outcomes for people with cognitive, psychiatric and/or neurological symptoms, their families, clinicians and healthcare systems.
We are welcoming healthcare professionals to refer people with symptoms (and healthy controls) or if you are an individual interested in participating, please discuss a referral with your GP, treating specialist, or other healthcare professional. Alternatively, please contact us.
You could be eligible if:
- You are aged 40 to 80 years.
- You, your family, or your doctor are worried about cognitive or psychiatric symptoms that are new or recent (within the last 5 years). Examples of cognitive symptoms (or problems with thinking) include problems with memory, problem-solving, finding words, or changes in personality or behaviour. Examples of psychiatric symptoms include changes in mood such as depression or mania, psychotic symptoms such as delusions or hallucinations. If you have a long history of a psychiatric illness/diagnosis, you may still be eligible if there have been recent changes in your symptoms or treatment needs.
- You have no current cognitive, psychiatric or neurological symptoms, illnesses or diagnoses (control group only).
For further information (including on other currently recruiting studies) please visit: https://themindstudy.org/. Participant Information and Consent forms are available at: https://themindstudy.org/picf/.
This study has been approved by the Melbourne Health Human Research Ethics Committee (approval number 2020.142).
Level 2/300 Grattan Street
Parkville VIC 3052